Tacrine as a treatment for Alzheimer's dementia: editor's note. An interim report from the FDA. A response from Summers et al.
D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D012107:Research Design; D013619:Tacrine / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D013619:Tacrine